DD202694A5 - Verfahren zur herstellung von peptiden - Google Patents

Verfahren zur herstellung von peptiden Download PDF

Info

Publication number
DD202694A5
DD202694A5 DD82239196A DD23919682A DD202694A5 DD 202694 A5 DD202694 A5 DD 202694A5 DD 82239196 A DD82239196 A DD 82239196A DD 23919682 A DD23919682 A DD 23919682A DD 202694 A5 DD202694 A5 DD 202694A5
Authority
DD
German Democratic Republic
Prior art keywords
phe
pro
item
nal
peptides
Prior art date
Application number
DD82239196A
Other languages
German (de)
English (en)
Inventor
Jean E F Rivier
Wylie W Vale
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of DD202694A5 publication Critical patent/DD202694A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD82239196A 1981-04-21 1982-04-21 Verfahren zur herstellung von peptiden DD202694A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/256,063 US4409208A (en) 1980-04-15 1981-04-21 GnRH antagonists

Publications (1)

Publication Number Publication Date
DD202694A5 true DD202694A5 (de) 1983-09-28

Family

ID=22970967

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82239196A DD202694A5 (de) 1981-04-21 1982-04-21 Verfahren zur herstellung von peptiden

Country Status (20)

Country Link
US (1) US4409208A (da)
EP (1) EP0063423B1 (da)
JP (1) JPS57181047A (da)
KR (1) KR830010052A (da)
AT (1) ATE14886T1 (da)
AU (1) AU551892B2 (da)
CA (1) CA1241950A (da)
CS (1) CS228924B2 (da)
DD (1) DD202694A5 (da)
DE (1) DE3265349D1 (da)
DK (1) DK151033C (da)
ES (1) ES511525A0 (da)
GR (1) GR75542B (da)
HU (1) HU186007B (da)
IE (1) IE52442B1 (da)
IL (1) IL65371A (da)
NO (1) NO821274L (da)
NZ (1) NZ200125A (da)
PH (1) PH18965A (da)
ZA (1) ZA822053B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58162562A (ja) * 1982-03-05 1983-09-27 シンテツクス・(ユ−・エス・エイ)・インコ−ポレ−テツド Lhrhのノナペプチド及びデカペプチドアナロ−グ
IL70888A0 (en) * 1983-03-10 1984-05-31 Salk Inst For Biological Studi Gn rh antagonist peptides and pharmaceutical compositions containing them
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
WO1988007056A1 (en) * 1987-03-10 1988-09-22 Eastern Virginia Medical Authority METHOD AND KIT FOR CONTRACEPTION WITH GnRH-ANTAGONIST AND PROGESTIN
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
CA2673128C (en) 2006-10-24 2018-07-03 Repros Therapeutics Inc. Compositions and methods for suppressing endometrial proliferation
US20220257695A1 (en) 2017-03-31 2022-08-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) A gnrh antagonist for use in the treatment of a women affected with polycystic ovary syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH11571A (en) * 1973-10-03 1978-03-31 American Home Prod P-gui-d-phe-trp-ser-tyr-d-ala-leu-arg-pro-gly-nh2,its non-toxic salts and method of use thereof
US3933782A (en) * 1974-11-14 1976-01-20 American Home Products Corporation (N-Acetyl)-Pro-D-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt and intermediates
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
GB2053229B (en) * 1979-06-13 1983-03-02 Schally Andrew Victor Lh-rh antagonists
US4253997A (en) * 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
NZ196558A (en) * 1980-04-15 1984-10-19 Salk Inst For Biological Studi Lrf antagonists and pharmaceutical compositions

Also Published As

Publication number Publication date
ES8307720A1 (es) 1983-07-16
DK151033B (da) 1987-10-12
HU186007B (en) 1985-05-28
DE3265349D1 (en) 1985-09-19
DK151033C (da) 1988-03-14
PH18965A (en) 1985-11-26
IE52442B1 (en) 1987-10-28
CS228924B2 (en) 1984-05-14
IE820819L (en) 1982-10-21
ZA822053B (en) 1983-02-23
EP0063423B1 (en) 1985-08-14
US4409208A (en) 1983-10-11
KR830010052A (ko) 1983-12-24
AU8283882A (en) 1982-10-28
NZ200125A (en) 1984-10-19
DK173082A (da) 1982-10-22
CA1241950A (en) 1988-09-13
ATE14886T1 (de) 1985-08-15
GR75542B (da) 1984-07-27
IL65371A (en) 1985-12-31
IL65371A0 (en) 1982-05-31
JPS57181047A (en) 1982-11-08
NO821274L (no) 1982-10-22
EP0063423A1 (en) 1982-10-27
ES511525A0 (es) 1983-07-16
AU551892B2 (en) 1986-05-15

Similar Documents

Publication Publication Date Title
DD216923A5 (de) Verfahren zur herstellung eines peptids
DD248365A5 (de) Gnrh-antagonisten vi
DE69833751T2 (de) IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN
DD235874A5 (de) Verfahren zur herstellung eines peptides
US4410514A (en) GnRH Agonists
CH639362A5 (de) Arzneimittel zur verhinderung der fortpflanzung bei maennlichen saeugetieren einschliesslich menschen.
JPH0132838B2 (da)
DD247009A5 (de) Peptide, enthaltend eine aliphatisch-aromatische keton-seitenkette
DD245881A5 (de) Gnrh antagonisten ix
DD202694A5 (de) Verfahren zur herstellung von peptiden
DE3687532T2 (de) Zyklische hexapeptid-lhrh-antagonisten.
DE2851630A1 (de) Peptide, die die geschlechtsdruesenfunktion inhibieren
US4292313A (en) LRF Antagonists
DE2547721A1 (de) Biologisch aktive amide
DE69125024T2 (de) Lhrh-antagonisten
US4740500A (en) GnRH antagonists VIII
DD220315A5 (de) Verfahren zur herstellung eines peptids
DE2708125C2 (da)
DE2726276A1 (de) Polypeptid
EP0038135B1 (en) Lrf antagonists
US4377574A (en) Contraceptive treatment of male mammals
US4261887A (en) Peptide compositions
DE2648829A1 (de) Nonapeptide, verfahren zu deren herstellung und diese enthaltende arzneimittel
KR910002702B1 (ko) 펩티드의 제법
DD241909A5 (de) Gnrh-antagonisten. vii